Form 13-F position report

INVO BIOSCIENCE INC COM PAR $0

Reported by MORGAN STANLEY

NAYA CUSIP 44984F401 Manager CIK 0000895421

Reported 37 shares, down 4 (9.8%) from the prior quarter.

Reported value 56.3%; share count -9.8% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2023
Shares 37 Quarter-end amount reported
Reported value $50 Fair value at quarter end
Consecutive quarters held 2 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-09-30 32
2023-12-31 50
2024-03-31 42
2024-06-30 31
2024-09-30 26
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for INVO BIOSCIENCE INC COM PAR $0 held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -37 (-100.0%) 0 $0 2025-02-14
Q3 2024 Unchanged 37 0 (0.0%) < 0.01% $26 2024-11-14
Q2 2024 Unchanged 37 0 (0.0%) < 0.01% $31 2024-08-14
Q1 2024 Unchanged 37 0 (0.0%) < 0.01% $42 2024-05-15
Q4 2023 Reduced 37 -4 (-9.8%) < 0.01% $50 2024-02-13
Q3 2023 New 41 +41 (0.0%) < 0.01% $32 2023-11-15

Who else reported the position

14 managers reported INVO BIOSCIENCE INC COM PAR $0 for Q4 2023.

Managers reporting INVO BIOSCIENCE INC COM PAR $0 in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC New 54,058 +54,058 < 0.01% $72,978 1 qtr
GEODE CAPITAL MANAGEMENT LLC Added 26,826 +12,420 < 0.01% $36,215 2 qtrs
SABBY MANAGEMENT LLC Reduced 18,624 -212,399 0.03% $25,142 2 qtrs
UBS Group AG New 7,155 +7,155 < 0.01% $9,659 1 qtr
Tower Research Capital LLC TRC Added 4,945 +2,262 < 0.01% $6,676 2 qtrs
ROYAL BANK OF CANADA Unchanged 538 0 < 0.01% $1,000 2 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 559 -50 < 0.01% $755 2 qtrs
Aspire Private Capital LLC Unchanged 115 0 < 0.01% $155 2 qtrs
MORGAN STANLEY This report Reduced 37 -4 < 0.01% $50 2 qtrs
BlackRock Inc Unchanged 24 0 < 0.01% $32 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 13, 2024
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
0
None
37

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.